Chinese venture firm Quan Capital is seeking to raise US$300 million for its second biomedical-focused fund, according to a regulatory filing. The target is double the amount the firm managed to raise for its debut fund, Quan Venture Fund L.P. With US$150 million secured in August 2017, the earlier fund eyed investments in novel therapeutics and related areas such as other enabling technologies. Among the companies backed by the first fund was Crescendo Biologics Ltd, a Cambridge-based developer of multi-functional … China’s Quan Capital Seeks US$300M For Second Healthcare Fund appeared first on China Money Network.